Cargando…

Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study

BACKGROUND: Encephalitis, the inflammation of the brain, may be caused by an infection or an autoimmune reaction. However, few researches were focused on the gut microbiome characteristics in encephalitis patients. METHODS: A prospective observational study was conducted in an academic hospital in G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ruoting, Tan, Chuhong, He, Yan, Wu, Qiheng, Wang, Huidi, Yin, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468513/ https://www.ncbi.nlm.nih.gov/pubmed/32973805 http://dx.doi.org/10.3389/fimmu.2020.01994

Ejemplares similares

Dysbiosis of Gut Microbiota and Short‐Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes
por: Tan, Chuhong, et al.
Publicado: (2020)

Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
por: Xu, Ruoting, et al.
Publicado: (2019)

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
por: Tan, Chuhong, et al.
Publicado: (2020)

Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2017)

Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis
por: Saresella, Marina, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders
por: Bojović, Katarina, et al.
Publicado: (2020)

Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2017)

The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
por: Tao, Pengyu, et al.
Publicado: (2022)

Associations between dysbiosis gut microbiota and changes of neurotransmitters and short-chain fatty acids in valproic acid model rats
por: Zhong, Jiu-Gen, et al.
Publicado: (2023)

Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
por: Lou, Xiran, et al.
Publicado: (2023)

Vancomycin-induced gut microbiota dysbiosis aggravates allergic rhinitis in mice by altered short-chain fatty acids
por: Chen, Zhen, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
por: Teramoto, Yoshiki, et al.
Publicado: (2023)

Female Gut and Genital Tract Microbiota-Induced Crosstalk and Differential Effects of Short-Chain Fatty Acids on Immune Sequelae
por: Amabebe, Emmanuel, et al.
Publicado: (2020)

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
por: Dong, Yue, et al.
Publicado: (2023)

Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
por: Ancona, Giuseppe, et al.
Publicado: (2023)

Gut Microbial Dysbiosis Associated with Type 2 Diabetes Aggravates Acute Ischemic Stroke
por: Chen, Xiaojiao, et al.
Publicado: (2021)

Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains
por: Zou, Yeqing, et al.
Publicado: (2022)

Normal Light-Dark and Short-Light Cycles Regulate Intestinal Inflammation, Circulating Short-chain Fatty Acids and Gut Microbiota in Period2 Gene Knockout Mice
por: Zhen, Yongkang, et al.
Publicado: (2022)

Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder
por: Liu, Simeng, et al.
Publicado: (2019)

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines
por: Feng, Wuwen, et al.
Publicado: (2018)

Dysbiosis of Gut Microbiota Is an Independent Risk Factor of Stroke-Associated Pneumonia: A Chinese Pilot Study
por: Xia, Geng-Hong, et al.
Publicado: (2021)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

Aging-Induced Dysbiosis of Gut Microbiota as a Risk Factor for Increased Listeria monocytogenes Infection
por: Alam, Mohammad S., et al.
Publicado: (2021)

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
por: Pan, Quanren, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer’s Disease and Obesity
por: Zhang, Boqi, et al.
Publicado: (2022)

The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial
por: Xu, Dengfeng, et al.
Publicado: (2021)

Altered Gut Microbiota and Short-chain Fatty Acids in Chinese Children with Constipated Autism Spectrum Disorder
por: He, Jianquan, et al.
Publicado: (2023)

Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation
por: Kim, Chang H., et al.
Publicado: (2014)

Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017)

The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
por: Wu, Yeshun, et al.
Publicado: (2021)

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
por: Portincasa, Piero, et al.
Publicado: (2022)

Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure
por: Zhao, Peng, et al.
Publicado: (2022)

Antibiotics-Induced Dysbiosis of Intestinal Microbiota Aggravates Atopic Dermatitis in Mice by Altered Short-Chain Fatty Acids
por: Kim, Ha-Jung, et al.
Publicado: (2019)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
por: Silva, Ygor Parladore, et al.
Publicado: (2020)

Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
por: Akhtar, Muhammad, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases
por: Li, Xuan, et al.
Publicado: (2017)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection
por: Zhang, Yu, et al.
Publicado: (2023)

Regulation of short-chain fatty acids in the immune system
por: Liu, Xiao-feng, et al.
Publicado: (2023)

Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver disease
por: Bao, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k17qi0ecn5rc3gh88nt2kg265b